Skip to main content

Gilead Sciences, Inc 8-K, filed Oct 29, 2026

Gilead Sciences, Inc. (GILD)

8-K 2026-10-29 For: 2026-10-29
View Original
Added on October 29, 2026

About this 8-K

Gilead Sciences, Inc filed this 8-K on October 29, 2026.

Gilead Sciences reported third-quarter 2026 product sales of $8.3 billion, up 13%, and raised full-year product sales guidance to $31,000-$31,300 million. Full-year GAAP diluted loss per share is now $(4.40)-$(4.05), while non-GAAP diluted loss per share is $(1.20)-$(0.85). AI summary

Items reported

  • Item 2.02: Financial results
  • Item 9.01: Financial statements and exhibits